| 产品描述: | CYP2 选择性抑制剂 | 化学品;CYP2 Selective Inhibitors | Chemicals;;InformationAPD-597 (JNJ-38431055) is a potent and selectiveG protein-coupled receptor 119 (GPR119)agonist with EC50 of 46 nM for hGPR119 and an inhibitor ofCytochrome P450 2C9 (CYP2C9)with IC50 of 5.8 μM. APD-597 (JNJ-38431055) is developed for treating Type 2 diabetes (T2D).TargetshGPR119 (Cell-free assay); CYP2C9 (Cell-free assay) 46 nM(EC50); 5.8 μM |
| 体内研究: |
APD597 (20 mg/kg,口服,单剂量) 可提高 ICR 小鼠中葡萄糖诱导的总 GLP-1 和 GIP 水平。 |
| 参考文献: |
1. Buzard DJ, et al. Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonists. Bioorg Med Chem Lett. 2014 Sep 1;24(17):4332-4335. 2. Huan Y, et al. The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo. Sci Rep. 2017 Jun 28;7(1):4351. 3. Semple G, et al. Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improvedprofile. Bioorg Med Chem Lett. 2012 Feb 15;22(4):1750-1755. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.085 ml |
10.426 ml |
20.853 ml |
| 5 mM |
0.417 ml |
2.085 ml |
4.171 ml |
| 10 mM |
0.209 ml |
1.043 ml |
2.085 ml |
| 50 mM |
0.042 ml |
0.209 ml |
0.417 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |